Summary of opinion: Spevigo, 25/07/2024 Positive
Submitted by Anonymous (not verified) on 26 July 2024 - 11:00
Summary of opinion: Spevigo, 25/07/2024 Positive
Summary of opinion: Tecentriq, 25/07/2024 Positive
Submitted by Anonymous (not verified) on 26 July 2024 - 11:00
Summary of opinion: Tecentriq, 25/07/2024 Positive
Summary of opinion: Opsumit, 25/07/2024 Positive
Submitted by Anonymous (not verified) on 26 July 2024 - 11:00
Summary of opinion: Opsumit, 25/07/2024 Positive
EMA advises about risks of using weight loss medicine Mysimba with opioids
Submitted by Anonymous (not verified) on 26 July 2024 - 11:00
EMA advises about risks of using weight loss medicine Mysimba with opioids
Summary of opinion: Arexvy, 25/07/2024 Positive
Submitted by Anonymous (not verified) on 26 July 2024 - 11:00
Summary of opinion: Arexvy, 25/07/2024 Positive
Declaration of interests: Silvy da Rocha Dias
Submitted by Anonymous (not verified) on 26 July 2024 - 10:56
Declaration of interests: Silvy da Rocha Dias
Conduct of bioequivalence studies for veterinary medicinal products - Scientific guideline
Submitted by Anonymous (not verified) on 26 July 2024 - 10:32
Conduct of bioequivalence studies for veterinary medicinal products - Scientific guideline
Concept paper for the revision of the guideline on the conduct of bioequivalence studies for veterinary medicinal products (EMA/CVMP/016/2000-Rev.4)
Submitted by Anonymous (not verified) on 26 July 2024 - 10:29
Concept paper for the revision of the guideline on the conduct of bioequivalence studies for veterinary medicinal products (EMA/CVMP/016/2000-Rev.4)
Product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 26 July 2024 - 10:28
Product-specific bioequivalence guidance
Concept paper on the revision of the guideline on user safety for pharmaceutical veterinary medicinal products (EMA/CVMP/543/03-Rev.1)
Submitted by Anonymous (not verified) on 26 July 2024 - 10:20
Concept paper on the revision of the guideline on user safety for pharmaceutical veterinary medicinal products (EMA/CVMP/543/03-Rev.1)